The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Prosvetov A.O.
Evdokimov Moscow State University of Medicine and Dentistry
Tsygankov B.D.
Evdokimov Moscow State University of Medicine and Dentistry
Guekht A.B.
Solov’ev Research and Clinical Center for Neuropsychiatry
Kuznetsov E.V.
Evdokimov Moscow State University of Medicine and Dentistry
Less U.E.
Moscow Research and Clinical Center for Neuropsychiatry
Popov G.R.
Moscow Research and Clinical Center for Neuropsychiatry
Tsygankov D.B.
Institute of Mental Health and Addictology
Rangus S.R.
Evdokimov Moscow State University of Medicine and Dentistry
Transcranial magnetic stimulation in the treatment of depressive disorder in Parkinson’s disease
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(9): 79‑85
Views: 2080
Downloaded: 49
To cite this article:
Prosvetov AO, Tsygankov BD, Guekht AB, et al. . Transcranial magnetic stimulation in the treatment of depressive disorder in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry.
2022;122(9):79‑85. (In Russ.)
https://doi.org/10.17116/jnevro202212209179
The prevalence of affective disorders in patients with Parkinson’s disease (PD) is significantly higher than in the general population of people of the same age. It is known that the effectiveness of antidepressants in PD with depressive disorder is lower than in patients with primary depression. For depression resistant to standard treatments, other therapeutic strategies are available. Transcranial magnetic stimulation (TMS) is one of the most popular and safe brain stimulation methods that has been successfully used to treat primary depression. The accumulation of experience in the use of TMS has made it possible to expand the application of the method to other diseases, including PD. The article provides literature data on the use of different TMS protocols for the treatment of depressive disorder in patients with PD.
Keywords:
Authors:
Prosvetov A.O.
Evdokimov Moscow State University of Medicine and Dentistry
Tsygankov B.D.
Evdokimov Moscow State University of Medicine and Dentistry
Guekht A.B.
Solov’ev Research and Clinical Center for Neuropsychiatry
Kuznetsov E.V.
Evdokimov Moscow State University of Medicine and Dentistry
Less U.E.
Moscow Research and Clinical Center for Neuropsychiatry
Popov G.R.
Moscow Research and Clinical Center for Neuropsychiatry
Tsygankov D.B.
Institute of Mental Health and Addictology
Rangus S.R.
Evdokimov Moscow State University of Medicine and Dentistry
Received:
14.03.2022
Accepted:
15.03.2022
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.